Quotient Clinical, the Translational Pharmaceutics Company, has announced the initiation of a new RapidFACT program for Druggability Technologies (DRGT) for evaluating enhanced formulations of abiratone acetate, a marketed drug prescribed in combination with prednisone to patients suffering from metastatic prostate cancer.
Prostate cancer project aims to reduce dose and food effects
Jun 23, 2015
Machinery Basics
Retail multipack suppliers, all in one place
25+ vetted systems for cups, tubs, and bottles — shrink, paperboard, banding, clip, and more. Free download.
Read More
Co-packers: the competitive gap is widening
Brands want more than low bids. See what automation, services, and sustainability mean for CM/CPs in 2026.
Read More



















